Chen, Ziang
Ou, Yuxi
Ye, Fangdie
Li, Weijian
Jiang, Haowen
Liu, Shenghua
Funding for this research was provided by:
National Natural Science Foundation of China (81802569, 81802569, 81802569, 81802569, 81802569, 81802569)
Leading Talent Program by Shanghai Municipal Health Commission (2022LJ008, 2022LJ008, 2022LJ008, 2022LJ008, 2022LJ008, 2022LJ008)
Medical Innovation Research Special Project by Science and Technology Commission of Shanghai Municipality (22Y21900200, 22Y21900200, 22Y21900200, 22Y21900200, 22Y21900200, 22Y21900200)
Clinical Scientific and Technological Innovation Project by Shanghai Hospital Development Center (SHDC12021104, SHDC12021104, SHDC12021104, SHDC12021104, SHDC12021104, SHDC12021104)
Article History
Received: 5 March 2024
Accepted: 10 May 2024
First Online: 20 May 2024
Declarations
:
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.